Prensa
Área de prensa
La prensa está hablando de OPTIMA- vea a continuación nuestra cobertura de medios y comunicados de prensa enviados por el proyecto.
Cobertura mediática
Handelsblatt Live: Mit Künstlicher Intelligenz und in Kooperation können wir Krebs die Stirn bieten
Article Handelsblatt Live: Mit Künstlicher Intelligenz und in Kooperation können wir Krebs die Stirn bieten
Charles² – Pharma Insights – Mit künstlicher Intelligenz Krebs besser behandeln
Podcast: Charles² – Pharma Insights
No real data, no real risk? Circumventing legal privacy concerns in Artificial Intelligence/Machine Learning models with synthetic data
Blogpost: Future-Law
OPTIMA – optimierte Krebsbehandlung mit Big Data und KI
Article in Podcast ONKO3.0
Big Data is curing you
Article in Medical Tribune
Projekt OPTIMA startet mit ersten Prototypen
Article in Handeslblatt Inside – DIGITAL HEALTH
Astrazeneca, Mutabor Are Now Recognised As Allies By OPTIMA
Article in World Pharma Today
OPTIMA Has Made AstraZeneca And Mutabor Official Partners
Article in Pharma Advancement
Optima mit zwei neuen Mitgliedern
Article in Healthcare Marketing
Internasjonalt AI-prosjekt velger AstraZeneca som partner
Article in Dagens Medisin
OPTIMA announce AstraZeneca and Mutabor as official partners
Article in Compass Life Science
Comunicados de prensa
OPTIMA Press Release – January 2024
OPTIMA, the international research consortium, announces the Region Uppsala as official partner.
OPTIMA Press Release – October 2022
OPTIMA, the international research consortium, announces AstraZeneca and MUTABOR as official partners
OPTIMA Press Release – October 2021
OPTIMA: New research project aims to improve treatment for patients with prostate, breast and lung cancer through artificial intelligence
